Biblio
“Analysis of neurodegenerative Mendelian genes in clinically diagnosed Alzheimer Disease.”, PLoS Genet, vol. 13, no. 11, p. e1007045, 2017.
, “Apolipoprotein E in Alzheimer's disease risk and case detection: a case-control study.”, J Clin Epidemiol, vol. 49, no. 10, pp. 1143-8, 1996.
, “A genome-wide scan for common variants affecting the rate of age-related cognitive decline.”, Neurobiol Aging, vol. 33, no. 5, pp. 1017.e1-15, 2012.
, “Analysis of lipid pathway genes indicates association of sequence variation near SREBF1/TOM1L2/ATPAF2 with dementia risk.”, Hum Mol Genet, vol. 19, no. 10, pp. 2068-78, 2010.
, “Changes in the prevalence of chronic disability in the United States black and nonblack population above age 65 from 1982 to 1999.”, Proc Natl Acad Sci U S A, vol. 98, no. 11, pp. 6354-9, 2001.
, “Alzheimer's disease risk genes and the age-at-onset phenotype.”, Neurobiol Aging, vol. 34, no. 11, pp. 2696.e1-5, 2013.
, “A potential endophenotype for Alzheimer's disease: cerebrospinal fluid clusterin.”, Neurobiol Aging, vol. 37, pp. 208.e1-208.e9, 2016.
, “Alzheimer disease pathology in cognitively healthy elderly: a genome-wide study.”, Neurobiol Aging, vol. 32, no. 12, pp. 2113-22, 2011.
, “Genetic Variation in Genes Underlying Diverse Dementias May Explain a Small Proportion of Cases in the Alzheimer's Disease Sequencing Project.”, Dement Geriatr Cogn Disord, vol. 45, no. 1-2, pp. 1-17, 2018.
, “Rarity of the Alzheimer disease-protective APP A673T variant in the United States.”, JAMA Neurol, vol. 72, no. 2, pp. 209-16, 2015.
, “Interaction between the alpha-T catenin gene (VR22) and APOE in Alzheimer's disease.”, J Med Genet, vol. 42, no. 10, pp. 787-92, 2005.
, “Genetic variation in PCDH11X is associated with susceptibility to late-onset Alzheimer's disease.”, Nat Genet, vol. 41, no. 2, pp. 192-8, 2009.
, “A multiancestral genome-wide exome array study of Alzheimer disease, frontotemporal dementia, and progressive supranuclear palsy.”, JAMA Neurol, vol. 72, no. 4, pp. 414-22, 2015.
, “Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.”, Alzheimers Dement, vol. 13, no. 2, pp. 119-129, 2017.
, “Overview and findings from the religious orders study.”, Curr Alzheimer Res, vol. 9, no. 6, pp. 628-45, 2012.
, “Risk of dementia among white and African American relatives of patients with Alzheimer disease.”, JAMA, vol. 287, no. 3, pp. 329-36, 2002.
, “Differences in apolipoprotein E3/3 and E4/4 allele-specific gene expression in hippocampus in Alzheimer disease.”, Neurobiol Dis, vol. 21, no. 2, pp. 256-75, 2006.
, “Revealing the role of glutathione S-transferase omega in age-at-onset of Alzheimer and Parkinson diseases.”, Neurobiol Aging, vol. 27, no. 8, pp. 1087-93, 2006.
, “Genome-wide linkage analyses of non-Hispanic white families identify novel loci for familial late-onset Alzheimer's disease.”, Alzheimers Dement, vol. 12, no. 1, pp. 2-10, 2016.
, “Genetically predicted body mass index and Alzheimer's disease-related phenotypes in three large samples: Mendelian randomization analyses.”, Alzheimers Dement, vol. 11, no. 12, pp. 1439-1451, 2015.
, “Variation in the urokinase-plasminogen activator gene does not explain the chromosome 10 linkage signal for late onset AD.”, Am J Med Genet B Neuropsychiatr Genet, vol. 124B, no. 1, pp. 29-37, 2004.
, “Association of apolipoprotein E genotype and Alzheimer disease in African Americans.”, Arch Neurol, vol. 63, no. 3, pp. 431-4, 2006.
, “Genome-wide association study identifies four novel loci associated with Alzheimer's endophenotypes and disease modifiers.”, Acta Neuropathol, vol. 133, no. 5, pp. 839-856, 2017.
, “Age-at-onset linkage analysis in Caribbean Hispanics with familial late-onset Alzheimer's disease.”, Neurogenetics, vol. 9, no. 1, pp. 51-60, 2008.
, “Lewy body pathology is a frequent co-pathology in familial Alzheimer's disease.”, Acta Neuropathol, vol. 105, no. 5, pp. 484-8, 2003.
,